Not yet recruiting
Small cell lung cancer limited stage
Not yet recruitingA Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer
Investigational
A Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer
Investigational
- Disease:Small cell lung cancer limited stage
- Substances:Trilaciclib dihydrochloride
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Trilaciclib dihydrochloride



